Qlarant is part of the IPRO Quality Improvement Organization (QIO) which includes Delaware, Maryland, District of Columbia, Maine, New Hampshire, Vermont, Massachusetts, Connecticut, Rhode Island, New York, New Jersey, and Ohio. The network was tasked with implementing strategies to facilitate quality improvement throughout these regions. The AQIN aligns with the DHHS National Quality Strategy, the CMS Agency strategy goals including: better care, better health and lower costs (Triple Aim), prevention and population health, expanded health care coverage and enterprise excellence. Four foundational principles include: eliminating disparities, strengthening infrastructure and data systems, enabling local innovations and fostering learning organizations.
As part of this QIN-QIO, Qlarant is dedicated to transforming health care and health care outcomes for patients. Our work will focus on several key quality improvement tasks including:
- Cardiac health and disparities in physician practices and Home Health Agencies
- Diabetes care and disparities through self-management
- Antibiotic stewardship
- Healthcare acquired nursing home conditions
- Care coordination to reduce admissions, readmissions and adverse drug events
- Clinician Quality Payment Program technical assistance
- Special Innovation Projects
- System-wide quality improvement initiatives from case review contractor referrals
- Immunization resources
Throughout our QIN-QIO work we will utilize results-oriented improvement approaches: use data to determine interventions that will be effective, involve patient and family at all phases of improvement efforts, focus on system-level interventions that can be sustained, use learning and action networks to convene stakeholders for large scale improvement and use technical assistance and coaching when needed.
